阿尔凯默斯将在2025年世界睡眠大会上公布Vibrance-1二期研究详细积极结果,该研究评估Alixorexton治疗1型嗜睡症患者的效果

美股速递
Aug 25

阿尔凯默斯将在2025年世界睡眠大会上公布Vibrance-1二期研究详细积极结果,该研究评估Alixorexton治疗1型嗜睡症患者的效果

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10